Loading clinical trials...
Loading clinical trials...
Multiple Sclerosis (MS) is the most common acquired neurological disease leading to disability, especially ambulatory, in young adults. To date, the correlation between the number or volume of white m...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rennes University Hospital
NCT05359653 · Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, and more
NCT06390930 · Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, and more
NCT03401879 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
NCT06389968 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
NCT05834855 · Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, and more
AP-HM Timone
Marseille
CHU Rennes
Rennes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions